According to a recent study published by Future Market Insights, the market for Oncolytic Virus Cancer Therapy is forecast to reach a valuation of US$ 22.86 Million by 2023-end, and will eventually reach US$ 250 Million by 2033, growing at an astronomical CAGR of 27%. Governments in various emerging economies have c.
Basel/Allschwil, Switzerland, December 19, 2022 Basilea Pharmaceutica Ltd. , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial. | December 19, 2022
South Korea s bourse operator on Wednesday decided to allow scandal-ridden bio firm Sillajen Inc. to resume its stock trading after a 2 1/2-year suspension
Korean bio ventures struggle with fundraising hankyung.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hankyung.com Daily Mail and Mail on Sunday newspapers.